Compare RANI & CLAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RANI | CLAR |
|---|---|---|
| Founded | 2012 | 1957 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Recreational Games/Products/Toys |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 126.8M | 106.0M |
| IPO Year | 2021 | 1998 |
| Metric | RANI | CLAR |
|---|---|---|
| Price | $0.96 | $2.91 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $7.50 | $4.08 |
| AVG Volume (30 Days) | ★ 1.4M | 155.8K |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 3.41% |
| EPS Growth | ★ 57.14 | 11.68 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,633,000.00 | $228,000.00 |
| Revenue This Year | $274.77 | $5.27 |
| Revenue Next Year | $79.44 | $3.99 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 58.85 | N/A |
| 52 Week Low | $0.39 | $2.59 |
| 52 Week High | $3.87 | $4.03 |
| Indicator | RANI | CLAR |
|---|---|---|
| Relative Strength Index (RSI) | 49.87 | 57.84 |
| Support Level | $0.45 | $2.59 |
| Resistance Level | $1.22 | $3.88 |
| Average True Range (ATR) | 0.09 | 0.08 |
| MACD | 0.03 | 0.05 |
| Stochastic Oscillator | 94.39 | 71.60 |
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.
Clarus Corp is a designer, developer, manufacturer, and distributor of outdoor equipment and lifestyle products focused on the climb, ski, mountain, sport, and skincare markets. The company operates through the Outdoor segment, which includes Black Diamond Equipment and PIEPS, is a world-wide leader in designing, manufacturing, and marketing outdoor engineered equipment and apparel for climbing, mountaineering, trail running, backpacking, skiing, and a wide range of other year-round outdoor recreation activities. The Adventure segment, which includes Rhino-Rack, MAXTRAX and TRED, is a manufacturer of engineered automotive roof racks, trays, mounting systems, luggage boxes, carriers, recovery boards and accessories in Australia and New Zealand and U.S.